Regulation of ryanodine receptor ion channels through posttranslational modifications

Current Topics in Membranes

Volumn 66, Issue C, 2010, Pages 91-113

  Meissner, Gerhard ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Ca 2+ release channels; Ca 2+ signaling; Muscle diseases; Protein phosphorylation; Reactive nitrogen species; Reactive oxygen species; Ryanodine receptors

Indexed keywords

EID: 77955113378     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1063-5823(10)66005-X     Document Type: Chapter

References (138)

1. Abramson J.J., Salama G. Critical sulfhydryls regulate calcium release from sarcoplasmic reticulum. Journal of Bioenergetics and Biomembranes 1989, 21:283-294.
2. 2+ release channel from oxidation induced activation. The Journal of Biological Chemistry 1997, 272:25462-25467.
3. 2+ release channel. The Journal of Biological Chemistry 1997, 272:3739-3748.
4. Anzai K., Ogawa K., Kuniyasu A., Ozawa T., Yamamoto H., Nakayama H. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochemical and Biophysical Research Communications 1998, 249:938-942.
5. 2+ activation of RyR1 channels. The Journal of Biological Chemistry 2003, 278:42927-42935.
6. Aracena-Parks P., Goonasekera S.A., Gilman C.P., Dirksen R.T., Hidalgo C., Hamilton S.L. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. The Journal of Biological Chemistry 2006, 281:40354-40368.
7. Arstall M.A., Sawyer D.B., Fukazawa R., Kelly R.A. Cytokine-mediated apoptosis in cardiac myocytes. The role of inducible nitric oxide synthase induction and peroxynitrite generation. Circulation Research 1999, 85:829-840.
8. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002, 416:337-339.
9. Bellinger A.M., Reiken S., Carlson C., Mongillo M., Liu X., Rothman L., et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Natural Medicines 2009, 15:325-330.
10. Bellinger A.M., Reiken S., Dura M., Murphy P.W., Deng S.X., Landry D.W., et al. Remodeling of ryanodine receptor complex causes "leaky" channels, a molecular mechanism for decreased exercise capacity. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2198-2202.
11. Bendall J.K., Damy T., Ratajczak P., Loyer X., Monceau V., Marty I., et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 2004, 110:2368-2375.
12. Benkusky N.A., Weber C.S., Scherman J.A., Farrell E.F., Hacker T.A., John M.C., et al. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circulation Research 2007, 101:819-829.
13. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
14. Blayney L.M., Jones J.L., Griffiths J., Lai F.A. A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201. Cardiovascular Research 2009, 85:68-78.
15. Brenman J.E., Chao D.S., Xia H., Aldape K., Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995, 82:743-752.
16. Brillantes A.B., Ondrias K., Scott A., Kobrinsky E., Ondriasova E., Moschella M.C., et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 1994, 77:513-523.
17. 2+ release channel. The Journal of Biological Chemistry 1994, 269:15876-15884.
18. Carter S., Coyler J., Sitsapesan R. Maximum phosphorylatioin of the cardiac ryanodine receptor at serine-2809 by protein kinase A produces unique modifications to channel gating and conductance not observed at lower levels to phosphorylation. Circulation Research 2006, 98:1506-1513.
19. 2+ leak promotes atrial fibrillation in mice. The Journal of Clinical Investigation 2009, 119:1940-1951.
20. 2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 2005, 37:87-96.
21. Cheong E., Tumbev V., Stoyanovsky D., Salama G. Effects of pO(2) on the activation of skeletal muscle ryanodine receptors by NO, A cautionary note. Cell Calcium 2005, 38:481-488.
22. Currie S., Loughrey C.M., Craig M.A., Smith G.L. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart. The Biochemical Journal 2004, 277:357-366.
23. Damy T., Ratajczak P., Shah A.M., Camors E., Marty I., Hasenfuss G., et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 2004, 363:1365-1367.
24. 2+ release channel of skeletal muscle sarcoplasmic reticulum (ryanodine receptor isoform 1). The Journal of Biological Chemistry 2004, 279:37566-37574.
25. 2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1). Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16725-16730.
26. Dulhunty A.F., Laver D., Curtis S.M., Pace S., Haarmann C., Gallant E.M. Characteristics of irreversible ATP activation suggest that native skeletal ryanodine receptors can be phosphorylated via an endogenous CaMKII. Biophysical Journal 2001, 81:3240-3252.
27. Durham W.J., Aracena-Parks P., Long C., Rossi A.E., Goonasekera S.A., Boncompagni S., et al. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 2008, 133:53-65.
28. 2+ stimulates ERK, CREB, early genes. Journal of Cellular Physiology 2006, 209:379-388.
29. Eu J.P., Hare J.M., Hess D.T., Skaf M., Sun J., Cardenas-Navina I., et al. Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15229-15234.
30. 2 sensor and NO signaling functions. Cell 2000, 102:499-509.
31. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. The American Journal of Physiology 1983, 245:C1-C14.
32. Fauconnier J., Thireau J., Reiken S., Cassan C., Richard S., Matecki S., et al. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1559-1564.
33. Feng W., Liu G., Allen P.D., Pessah I.N. Transmembrane redox sensor of ryanodine receptor complex. The Journal of Biological Chemistry 2000, 275:35902-35907.
34. Feron O., Belhassen L., Kobzik L., Smith T.W., Kelly R.A., Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. The Journal of Biological Chemistry 1996, 271:22810-22814.
35. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiological Reviews 2002, 82:893-922.
36. Franzini-Armstrong C., Protasi F. Ryanodine receptors of striated muscles, a complex channel capable of multiple interactions. Physiological Reviews 1997, 77:699-729.
37. 2+ release channels are differentially expressed in rabbit brain. The Journal of Neuroscience 1994, 14:4794-4805.
38. Gellen B., Fernandez-Velasco M., Briec F., Vinet L., LeQuang K., Rouet-Benzineb P., et al. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation 2008, 117:1778-1786.
39. Gonzalez D.R., Beigi F., Treuer A.V., Hare J.M. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:20612-20617.
40. Hain J., Onoue H., Mayrleitner M., Fleischer S., Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. The Journal of Biological Chemistry 1995, 270:2074-2081.
41. Hart J.D., Dulhunty A.F. Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding. The Journal of Membrane Biology 2000, 173:227-336.
42. Hasumi H., Matsuda R., Shimamoto K., Hata Y., Kaneko N. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. European Journal of Pharmacology 2007, 555:54-60.
43. Hess D.T., Matsumoto A., Nudelman R., Stamler J.S. S-nitrosylation, spectrum and specificity. Nature Cell Biology 2001, 3:E46-E49.
44. Hidalgo C., Sanchez G., Barrientos G., Aracena-Parks P. A transverse tubule NOX activity stimulates calcium release from isolated triads via RYR1 S-Glutathionylation. The Journal of Biological Chemistry 2006, 281:26473-26482.
45. Hohenegger M., Suko J. Phosphorylation of the purified cardiac ryanodine receptor by exogenous and endogenous protein kinases. The Biochemical Journal 1993, 296:303-308.
46. 3 H]ryanodine binding to RyR2 irrespective of FKBP12.6 association. The Biochemical Journal 2007, 404:431-438.
47. Janssens S., Pokreisz P., Schoonjans L., Pellens M., Vermeersch P., Tjwa M., et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation Research 2004, 94:1256-1262.
48. Ji L.L. Exercise-induced oxidative stress in the heart. Handbook of exercise and oxygen toxity 2000, 689-712. Elsevier Science, Amsterdam, The Netherlands. C.K. Sen, L. Packer, O. Hanninen (Eds.).
49. 2+ release, but normal ryanodine receptors, in canine and human heart failure. [comment]. Circulation Research 2002, 91:1015-1022.
50. Jones P.P., Meng X., Xiao B., Cai S., Bolstad J., Wagenknecht T., et al. Localization of PKA phosphorylation site, Ser(2030), in the three-dimensional structure of cardiac ryanodine receptor. The Biochemical Journal 2008, 410:261-270.
51. Jurynec M.J., Xia R., Mackrill J.J., Gunther D., Crawford T., Flanigan K.M., et al. Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:12485-12490.
52. Kanski J., Hong S.J., Schoneich C. Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. The Journal of Biological Chemistry 2005, 280:24261-24266.
53. 2+ channel. Molecular Pharmacology 1998, 53:497-503.
54. Khan S.A., Lee K., Minhas K.M., Gonzalez D.R., Raju S.V., Tejani A.D., et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15944-15948.
55. Koch W.J. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure. Molecular and Cellular Biochemistry 2004, 263:5-9.
56. Lam E., Martin M.M., Timerman A.P., Sabers C., Fleischer S., Lukas T., et al. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. The Journal of Biological Chemistry 1995, 270:26511-26522.
57. Lefer D.J., Scalia R., Campbell B., Nossuli T., Hayward R., Salamon M., et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. The Journal of Clinical Investigation 1997, 99:684-691.
58. 2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. The Journal of Clinical Investigation 2008, 118:2230-2245.
59. Lehnart S.E., Wehrens X.H., Reiken S., Warrier S., Belevych A.E., Harvey R.D., et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 2005, 123:25-35.
60. Li Y., Kranias E.G., Mignery G.A., Bers D.M. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circulation Research 2002, 90:309-316.
61. 2+ /calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. The Journal of Clinical Investigation 2009, 119:1230-1240.
62. Liu G., Abramson J.J., Zable A.C., Pessah I.N. Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethylamino-3-(4-maleimidylphenyl)-4-methylcoumarin. Molecular Pharmaceutics 1994, 45:189-200.
63. MacDonnell S.M., Garcia-Rivas G., Scherman J.A., Kubo H., Chen X., Valdivia H., et al. Adrenergic regulation of cardiac contractility does not involve phoshorylation of cardiac ryanodine receptor at serine 2808. Circulation Research 2008, 102:e65-e72.
64. 2+ release. Circulation Research 2003, 92:904-911.
65. Marinov B.S., Olojo R.O., Xia R., Abramson J.J. Non-thiol reagents regulate ryanodine receptor function by redox interactions that modify reactive thiols. Antioxidants Redox Signaling 2007, 9:609-621.
66. Marx S.O., Gaburjakova J., Gaburjakova M., Henrikson C., Ondrias K., Marks A.R. Coupled gating between cardiac calcium release channels (ryanodine receptors). Circulation Research 2001, 88:1151-1158.
67. Marx S.O., Reiken S., Hisamatsu Y., Gaburjakova M., Gaburjakova J., Yang Y.M., et al. Phosphorylation-dependent regulation of ryanodine receptors, a novel role for leucine/isoleucine zippers. The Journal of Cell Biology 2001, 153:699-708.
68. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor), defective regulation in failing hearts. Cell 2000, 101:365-376.
69. 2+ release channels and their regulation by endogenous effectors. Annual Review of Physiology 1994, 56:485-508.
70. Meissner G. Regulation of mammalian ryanodine receptors. Frontiers in Bioscience 2002, 7:d2072-d2080.
71. Meng X., Xiao B., Cai S., Huang X., Li F., Bolstad J., et al. Three-dimensional localization of serine-2808, a phosphorylation site in cardiac ryanodine receptor. The Journal of Biological Chemistry 2007, 282:25929-25939.
72. Meszaros L.G., Minarovic I., Zahradnikova A. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Letters 1996, 380:49-52.
73. Michikawa T., Hamanaka H., Otsu H., Yamamoto A., Miyawaki A., Furuichi T., et al. Transmembrane topology and sites of N-glycosylation of inositol 1,4,5-trisphosphate receptor. The Journal of Biological Chemistry 1994, 269:9184-9189.
74. 2+ release channels are expressed in vascular smooth muscle. Biochemical and Biophysical Research Communications 1995, 215:814-821.
75. Node K., Kitakaze M., Kosaka H., Komamura K., Minamino T., Inoue M., et al. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation 1996, 93:356-364.
76. 2 -induced channel activation are on luminal side of ryanodine receptors. The American Journal of Physiology 1998, 274:C914-C921.
77. Oda T., Yano M., Yamamoto T., Tokuhisa T., Okuda S., Doi M., et al. Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 2005, 111:3400-3410.
78. Petrotchenko E.V., Pasek D., Elms P., Dokholyan N.V., Meissner G., Borchers C.H. Combining fluorescence detection and mass spectrometric analysis for comprehensive and quantitative analysis of redox-sensitive cysteines in native membrane proteins. Analytical Chemistry 2006, 78:7959-7966.
79. Porter Moore C., Zhang J.Z., Hamilton S.L. A role for cysteine 3635 of RYR1 in redox modulation and calmodulin binding. The Journal of Biological Chemistry 1999, 274:36831-36834.
80. Quane K.A., Keating K.E., Healy J.M., Manning B.M., Krivosic-Horber R., Krivosic I., et al. Mutation screening of the RYR1 gene in malignant hyperthermia, detection of a novel Tyr to Ser mutation in a pedigree with associated central cores. Genomics 1994, 23:236-239.
81. Reid M.B. Reactive oxygen and nitric oxide in skeletal muscle. News in Physiological Sciences 1996, 11:114-121.
82. Reiken S., Gaburjakova M., Guatimosim S., Gomez A.M., D'Armiento J., Burkhoff D., et al. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. The Journal of Biological Chemistry 2003, 278:444-453.
83. Reiken S., Lacampagne A., Zhou H., Kherani A., Lehnart S.E., Ward C., et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle, defective regulation in heart failure. The Journal of Cell Biology 2003, 160:919-928.
84. Rios E., Pizarro G. Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiological Reviews 1991, 71:849-908.
85. Rodriguez P., Bhogal M.S., Colyer J. Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A. The Journal of Biological Chemistry 2003, 278:38593-38600.
86. Ruehr M.L., Russell M.A., Ferguson D.G., Bhat M., Ma J., Damron D.S., et al. Targeting of protein kinase A by muscle A kinase-anchoring protein (mAKAP) regulates phosphorylation and function of the skeletal muscle ryanodine receptor. The Journal of Biological Chemistry 2003, 278:24831-24836.
87. Sag C.M., Wadsack D.P., Khabbazzadeh S., Abesser M., Grefe C., Neumann K., et al. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Circulation. Heart failure 2009, 2:664-675.
88. Samso M., Feng W., Pessah I.N., Allen P.D. Corodinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biology 2009, 7:e85.
89. Sanchez G., Escobar M., Pedrozo Z., Macho P., Domenech R., Hartel S., et al. Exercise and tachycardia increase NADPH oxidase and ryanodine receptor-2 activity, possible role in cardioprotection. Cardiovascular Research 2008, 77:380-386.
90. 2+ ) release channel in skeletal muscle. Biophysical Journal 2002, 83:2539-2549.
91. Souza J.M., Peluffo G., Radi R. Protein tyrosine nitration-functional alteration or just a biomarker?. Free Radical Biology and Medicine 2008, 45:357-366.
92. Stamler J.S., Hausladen A. Oxidative modifications in nitrosative stress. Nature Structural Biology 1998, 5:247-249.
93. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiological Reviews 2001, 81:209-237.
94. Stange M., Xu L., Balshaw D., Yamaguchi N., Meissner G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. The Journal of Biological Chemistry 2003, 278:51693-51702.
95. Suko J., Drobny H., Hellmann G. Activation and inhibition of purified skeletal muscle calcium release channel by NO donors in single channel current recordings. Biochimica et Biophysica Acta 1999, 1451:271-287.
96. Suko J., Maurer-Fogy I., Plank B., Bertel O., Wyskovsky W., Hohenegger M., et al. Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase. Biochimica et Biophysica Acta 1993, 1175:193-206.
97. Sun J., Morgan M., Shen R.F., Steenbergen C., Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circulation Research 2007, 101:1155-1163.
98. 2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circulation Research 2006, 98:403-411.
99. Sun J., Xin C., Eu J.P., Stamler J.S., Meissner G. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:11158-11162.
100. Sun J., Xu L., Eu J.P., Stamler J.S., Meissner G. Classes of thiols that influence the activity of the skeletal muscle calcium release channel. The Journal of Biological Chemistry 2001, 276:15625-15630.
101. 2 in S-nitrosylation of the channel. The Journal of Biological Chemistry 2003, 278:8184-8189.
102. 2 tension and S-nitrosoglutathione. Biochemistry 2008, 47:13985-13990.
103. Takasago T., Imagawa T., Furukawa K., Ogurusu T., Shigekawa M. Regulation of the cardiac ryanodine receptor by protein kinase-dependent phosphorylation. Journal of Biochemistry (Tokyo) 1991, 109:163-170.
104. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 1989, 339:439-445.
105. Tang W.H., Kravtsov G.M., Sauert M., Tong X.Y., Hou X.Y., Wong T.M., et al. Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins. Journal of Molecular and Cellular Cardiology 2010, 49:58-69.
106. 2+ leak in failing hearts. Cardiovascular Research 2009, 81:536-545.
107. 2+ leak in chronic heart failure. Circulation Research 2008, 103:1466-1472.
108. 2+ cycling. Circulation Research 2007, 100:96-104.
109. Uehara A., Yasukochi M., Mejia-Alvarez R., Fill M., Imanaga I. Gating kinetics and ligand sensitivity modified by phosphorylation of cardiac ryanodine receptors. Pflugers Archiv 2002, 444:202-212.
110. 2+ and phosphorylation. Science 1995, 267:1997-2000.
111. Voss A.A., Lango J., Ernst-Russell M., Morin D., Pessah I.N. Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry. The Journal of Biological Chemistry 2004, 279:34514-34520.
112. Wang P., Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. The Journal of Biological Chemistry 1996, 271:29223-29230.
113. Ward C.W., Reiken S., Marks A.R., Marty I., Vassort G., Lacampagne A. Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats. The FASEB Journal 2003, 17:1517-1519.
114. Wehrens X.H., Lehnart S.E., Huang F., Vest J.A., Reiken S.R., Mohler P.J., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003, 113:829-840.
115. Wehrens X.H., Lehnart S.E., Reiken S.R., Deng S.X., Vest J.A., Cervantes D., et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004, 304:292-296.
116. 2+ /calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circulation Research 2004, 94:e61-e70.
117. Witcher D.R., Kovacs R.J., Schulman H., Cefali D.C., Jones L.R. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. The Journal of Biological Chemistry 1991, 266:11144-11152.
118. Xia R., Stangler T., Abramson J.J. Skeletal muscle ryanodine receptor is a redox sensor with a well defined redox potential that is sensitive to channel modulators. The Journal of Biological Chemistry 2000, 275:36556-36561.
119. Xia R., Webb J.A., Gnall L.L., Cutler K., Abramson J.J. Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. The American Journal of Physiology 2003, 285:C215-C221.
120. Xiao B., Jiang M.T., Zhao M., Yang D., Sutherland C., Lai F.A., et al. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circulation Research 2005, 96:847-855.
121. 2+ release. The Journal of Biological Chemistry 2007, 282:30256-30264.
122. Xiao B., Zhong G., Obayashi M., Yang D., Chen K., Walsh M.P., et al. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts. The Biochemical Journal 2006, 396:7-16.
123. Xiao J., Tian X., Jones P.P., Bolstad J., Kong H., Wang R., et al. Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias. The Journal of Biological Chemistry 2007, 282:34828-34838.
124. Xin H.B., Senbonmatsu T., Cheng D.S., Wang Y.X., Copello J.A., Ji G.J., et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002, 416:334-338.
125. Xu K.Y., Huso D.L., Dawson T.M., Bredt D.S., Becker L.C. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:657-662.
126. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998, 279:234-237.
127. 2+ release channel, ryanodine receptor. The Journal of Biological Chemistry 2001, 276:22579-22585.
128. 2+ waves in cardiac myocytes. Circulation Research 2007, 100:399-407.
129. Yano M., Kobayashi S., Kohno M., Doi M., Tokuhisa T., Okuda S., et al. FKBP12.6-mediated stabilizationof calcium-reelase channel (ryanodine receptor as a novel therapeutic strategey against heart failure. Circulation 2003, 107:477-484.
130. 2+ leak through ryanodine receptor in heart failure. Circulation 2000, 102:2131-2136.
131. Zahradnikova A., Minarovic I., Venema R.C., Meszaros L.G. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium 1997, 22:447-454.
132. Zalk R., Lehnart S.E., Marks A.R. Modulation of the ryanodine receptor and intracellular calcium. Ann. Rev. Biochem. 2007, 76:367-385.
133. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Natural Medicines 2005, 11:409-417.
134. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross J., Bers D.M., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circulation Research 2003, 92:912-919.
135. Zima A.V., Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovascular Research 2006, 71:310-321.
136. Zissimopoulos S., Docrat N., Lai F.A. Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. The Journal of Biological Chemistry 2007, 282:6976-6983.
137. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. The Journal of Biological Chemistry 1990, 265:2244-2256.
138. Zweier J.L., Wang P., Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. The Journal of Biological Chemistry 1995, 270:304-307.